Skip to content

Inogen INGN Goodwill

Goodwill at other companies

ResMed logo
ResMedRMD
$3.04B+6.8%
AdaptHealth logo
AdaptHealthAHCO
$2.57B-2.6%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$58.94M+78.7%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$2.33M0.0%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$39.55M+27.3%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$862K0.0%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's goodwill?
Inogen (INGN) reported goodwill of $10.48M in Q1 2026.
How has Inogen's goodwill changed year-over-year?
Inogen's goodwill increased by 6.3% year-over-year, from $9.86M to $10.48M.
What is the long-term trend for Inogen's goodwill?
Over 5 years (2020 to 2025), Inogen's goodwill has grown at a -20.3% compound annual growth rate (CAGR), from $33.17M to $10.7M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.